Christopher Kaster is a partner of MedVenture Associates (MVA) and has been with MVA since January 2003. Prior to joining MVA, Christopher worked as a senior equity research analyst with WR Hambrecht + Co., where he covered the medical device area, with an emphasis on small-cap, high growth companies. His research strategy was aimed at bringing true bottom-up investment analysis to the institutional client. Christopher currently serves on the board of directors of AesThera Corporation, PolyRemedy, Inc., and SaraTech, Inc.